6-Methyl-5-(1-methyl-1H-pyrazol-5-yl)-N-[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form.
6-甲基-5-(1-甲基-1H-
吡唑-5-基)-N-[5-(甲磺酰基)
吡啶-2-基]甲基}-2-氧代-1-[3-(三
氟甲基)苯基]-1,2-
二氢吡啶-3-羧酰胺
4-甲基苯磺酸盐及其一种新的结晶形式,以及制备这种盐和形式的方法,包含这种盐和形式的药物组合物,以及使用这种盐和形式进行治疗的方法。